NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/16/2017
Back to search
Official data from USPTO
HANNAH PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HANNAH PHARMACEUTICALS
ST13
US500000077039722Class
5
Filing
77039722
Registration
3382504
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
09/16/2017
Trademark type
Word
Nice classes
5
Filing date
11/08/2006
Registration date
02/12/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/16/2017
Last transaction
09/16/2017
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/20/2007
First use in commerce
01/20/2007
Drawing code
4
Owner type
16
Owner location
Portland, OR, US
Examiner
EULIN, INGRID
Law office
M20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Schuyler LLC
Representatives
Christopher D. Erickson TONKON TORP LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Multi-vitamin preparations for veterinary use; dietary and nutritional supplements for veterinary use; pharmaceutical preparations for pet skincare; pharmaceutical preparations for pet ear care; Antiparasitic preparations for veterinary use
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/16/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/16/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/16/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
08/08/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/12/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/18/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/18/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/17/2013
E815
TEAS SECTION 8 & 15 RECEIVED
07/02/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
02/12/2008
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
01/07/2008
ALIE
ASSIGNED TO LIE
01/07/2008
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/20/2007
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/19/2007
EX1G
SOU EXTENSION 1 GRANTED
11/19/2007
IUAF
USE AMENDMENT FILED
10/23/2007
EXT1
SOU EXTENSION 1 FILED
10/23/2007
EEXT
SOU TEAS EXTENSION RECEIVED
10/23/2007
EISU
TEAS STATEMENT OF USE RECEIVED
10/23/2007
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/31/2007
PUBO
PUBLISHED FOR OPPOSITION
05/08/2007
NPUB
NOTICE OF PUBLICATION
04/18/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/12/2007
ALIE
ASSIGNED TO LIE
03/12/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2007
GNRT
NON-FINAL ACTION E-MAILED
12/28/2006
CNRT
NON-FINAL ACTION WRITTEN
12/28/2006
DOCK
ASSIGNED TO EXAMINER
12/27/2006
NWAP
NEW APPLICATION ENTERED
11/14/2006
Continuous trademark protection
Get notified about every new filing that threatens HANNAH PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.